Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARCT | AMGN | BMY | GILD | ILMN |
| Company | Arcturus Therapeutics Ltd | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 26.90 | 312.89 | 44.75 | 64.72 | 111.35 |
| High | 27.79 | 314.89 | 44.97 | 66.20 | 112.24 |
| Low | 26.32 | 309.82 | 44.30 | 64.67 | 109.53 |
| Last | 27.26 | 310.15 | 44.94 | 65.96 | 110.53 |
| Change | +0.47 | -2.71 | +0.20 | +1.38 | -0.82 |
| % Change | +1.75% | -0.87% | +0.45% | +2.14% | -0.74% |
| Volume | 530,900 | 2,611,700 | 8,698,347 | 8,732,800 | 1,179,700 |
| 20-Day Average Volume | 495,770 | 2,930,855 | 14,168,250 | 7,614,355 | 1,625,610 |
| Previous Close | 26.79 | 312.86 | 44.74 | 64.58 | 111.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.21 | 281.61 | 46.01 | 65.99 | 119.04 |
| 20-Day Raw Stochastic | 33.76% | 79.89% | 25.81% | 39.52% | 10.08% |
| 20-Day Relative Strength | 43.24% | 65.95% | 36.90% | 39.82% | 35.33% |
| Weighted Alpha | -20.35 | +34.03 | -34.29 | -19.29 | -45.62 |
| Today's Opinion | 40% Sell | 56% Buy | 100% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 56% Sell | 56% Buy | 100% Sell | 100% Sell | 88% Sell |
| Last Month's Opinion | 40% Buy | 40% Sell | 56% Sell | 100% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.04% since 05/03/24 | -0.37% since 05/03/24 | +2.16% since 05/03/24 | +1.82% since 05/03/24 | -6.27% since 05/03/24 |
| Low | 26.28 on 05/09/24 | 297.52 on 05/06/24 | 43.49 on 05/09/24 | 64.34 on 05/06/24 | 108.54 on 05/08/24 |
| High | 29.08 on 05/09/24 | 314.89 on 05/10/24 | 44.97 on 05/10/24 | 66.20 on 05/10/24 | 119.43 on 05/07/24 |
| 1-Month | |||||
| %Chg | -14.38% since 04/10/24 | +16.40% since 04/10/24 | -10.64% since 04/10/24 | -3.17% since 04/10/24 | -15.74% since 04/10/24 |
| Low | 25.41 on 04/25/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 108.54 on 05/08/24 |
| High | 33.11 on 04/11/24 | 322.60 on 05/03/24 | 50.58 on 04/11/24 | 69.03 on 04/11/24 | 134.85 on 04/12/24 |
| 3-Month | |||||
| %Chg | -31.23% since 02/09/24 | +6.54% since 02/09/24 | -9.78% since 02/09/24 | -10.47% since 02/09/24 | -19.81% since 02/09/24 |
| Low | 25.41 on 04/25/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 108.54 on 05/08/24 |
| High | 43.81 on 02/27/24 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 147.25 on 02/16/24 |
| 6-Month | |||||
| %Chg | +42.28% since 11/10/23 | +16.03% since 11/10/23 | -11.20% since 11/10/23 | -13.12% since 11/10/23 | +12.36% since 11/10/23 |
| Low | 17.52 on 11/13/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 92.26 on 11/13/23 |
| High | 43.81 on 02/27/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 721,401 | 167,829,040 | 90,692,464 | 80,407,072 | 17,738,056 |
| Shares Outstanding, K | 26,928 | 536,435 | 2,027,100 | 1,245,077 | 159,300 |
| Annual Sales | 166,800,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -29,730,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 30,860,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 1,076,000,000 |
| Last Quarter Net Income | -11,710,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | -126,000,000 |
| 60-Month Beta | 2.65 | 0.60 | 0.45 | 0.22 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/07/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | 01/04/13 | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 41.59 | 16.11 | 125.70 |